DK164478C - Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon - Google Patents

Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon

Info

Publication number
DK164478C
DK164478C DK146785A DK146785A DK164478C DK 164478 C DK164478 C DK 164478C DK 146785 A DK146785 A DK 146785A DK 146785 A DK146785 A DK 146785A DK 164478 C DK164478 C DK 164478C
Authority
DK
Denmark
Prior art keywords
preparation
methyl
oxycarbonyldicyclohexylmethyloxypregna
9alpha
16alpha
Prior art date
Application number
DK146785A
Other languages
Danish (da)
English (en)
Other versions
DK164478B (da
DK146785D0 (da
DK146785A (da
Inventor
Francoise Delevallee
Roger Deraedt
Simone Jouquey
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK146785D0 publication Critical patent/DK146785D0/da
Publication of DK146785A publication Critical patent/DK146785A/da
Publication of DK164478B publication Critical patent/DK164478B/da
Application granted granted Critical
Publication of DK164478C publication Critical patent/DK164478C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK146785A 1984-04-03 1985-04-01 Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon DK164478C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8405222 1984-04-03
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Publications (4)

Publication Number Publication Date
DK146785D0 DK146785D0 (da) 1985-04-01
DK146785A DK146785A (da) 1985-10-04
DK164478B DK164478B (da) 1992-07-06
DK164478C true DK164478C (da) 1992-11-23

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
DK146785A DK164478C (da) 1984-04-03 1985-04-01 Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon

Country Status (16)

Country Link
US (1) US4614736A (pt)
EP (1) EP0161144B1 (pt)
JP (1) JPS60224615A (pt)
AT (1) ATE41604T1 (pt)
AU (1) AU571073B2 (pt)
CA (1) CA1226817A (pt)
DE (1) DE3568944D1 (pt)
DK (1) DK164478C (pt)
FR (1) FR2561919B1 (pt)
GR (1) GR850815B (pt)
HU (1) HU196122B (pt)
IL (1) IL74642A (pt)
MA (1) MA20388A1 (pt)
OA (1) OA07978A (pt)
PT (1) PT80214B (pt)
ZA (1) ZA851927B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
IL74642A (en) 1988-09-30
HU196122B (en) 1988-10-28
DK164478B (da) 1992-07-06
ATE41604T1 (de) 1989-04-15
DK146785D0 (da) 1985-04-01
FR2561919A1 (fr) 1985-10-04
AU571073B2 (en) 1988-03-31
IL74642A0 (en) 1985-06-30
FR2561919B1 (fr) 1986-12-19
EP0161144A1 (fr) 1985-11-13
DK146785A (da) 1985-10-04
DE3568944D1 (en) 1989-04-27
AU4080085A (en) 1985-10-10
PT80214A (en) 1985-05-01
JPS60224615A (ja) 1985-11-09
HUT44436A (en) 1988-03-28
CA1226817A (fr) 1987-09-15
GR850815B (pt) 1985-07-23
EP0161144B1 (fr) 1989-03-22
US4614736A (en) 1986-09-30
OA07978A (fr) 1987-01-31
PT80214B (en) 1987-02-17
MA20388A1 (fr) 1985-10-01
ZA851927B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
NO165547C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive androsta-1,4-dien-3,17-dioner.
FI95710C (fi) 9-alfa-hydroksi-steroidit, menetelmä niiden valmistamiseksi ja menetelmä vastaavien 9(11)-dehydro-johdannaisten valmistamiseksi
DE3485647D1 (de) Steroide und diese enthaltende therapeutische zusammensetzungen.
ATE31243T1 (de) Verwendung von 4-aminosalicylsaeure als entzuendungshemmender wirkstoff.
ES504340A0 (es) Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios
ATE229539T1 (de) Verfahren zur anreichung des verhältnisses der r- epimers von 16,17-acetal derivate von 21-acyloxy pregan-1,4-dien-11.beta.,16.alpha.,17.alpha.- triol-3,20-dionen
FI842457A0 (fi) 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter.
PH12415A (en) 16a,17-cyclopentylidenedioxy-9a-fluoro-11,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate,anti-inflammatory composition and method of use thereof
DK164478C (da) Anvendelse af 9alpha,11beta-dichlor-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion til fremstilling af et farmaceutisk praeparat til behandling af betaendelsestilstande i retcum eller colon
DK165879C (da) 11beta-chlor-delta15-steroider til anvendelse i antikonceptionspraeparater
BE831931A (fr) Nouveaux 17alpha, 21-diesters de 17alpha,21-dihydroxy steroides et leur preparation
ZA79538B (en) An anti-inflammatory steroid of the androstane series
BA97185B1 (bs) Postupak za dobijanje supstituisanih androsta-1,4-dien-3,17-diona
PH18966A (en) 19-nor steroids and 19-nor-d-homosteroids,method of use and pharmaceutical composition thereof
AR243198A1 (es) Procedimiento para la elaboracion de compuesto 9alfa-21-dihalogeno-11beta- hidroxi-17alfa-alcanoiloxi-6alfa-fluor-16beta-metilp regna-1,4-dien-3,20-diona
IT1188190B (it) Steroidi e procedimento per prepararli
ATE56726T1 (de) Aminoglykoside steroide, deren herstellungsverfahren, verwendung und arzneimittelzubereitungen, die diese enthalten.

Legal Events

Date Code Title Description
PBP Patent lapsed